Cognitive decline associated with aging and Alzheimer's disease (AD) is among the most common and debilitating conditions, and poses a large and increasing public health problem. Projections indicate that the prevalence of aging-related chronic conditions is expected to increase substantially in the next decade. This will be particularly true for minority populations, especially the older African American population, which is growing at an even more rapid pace than the older White population. The Minority Aging Research Study (MARS) is a longitudinal cohort study of more than 350 older African Americans without dementia who agreed to annual clinical evaluations. During the previous project period we identified several risk factors for cognitive decline in African Americans. The overall goal of the proposed continuation is to quantify three common neuropathologic indices including Alzheimer's disease pathology, cerebral infarctions, and Lewy bodies in MARS participants, and examine their associations to cognitive function and clinical risk factors. In addition, to increase power and examine racial differences in these associations, we propose to use existing longitudinal clinical and neuropathologic data on Whites from two other ongoing cohort studies at Rush.
Our Specific Aims are to: 1) examine the association of the three post-mortem neuropathologic indices to 1a: level of global cognition and five cognitive abilities, 1b: change in global cognition and five cognitive abilities;2) examine racial differences in the associations of neuropathology to level of and change in cognitive function;3) test the hypothesis that the APOE e4 allele is associated with increased levels of AD pathology, and the 52 allele is associated with a lower level of AD pathology in African Americans;and 4) examine the relationship of BMI to neuropathology, and test the hypothesis that BMI is more strongly associated with AD pathology in Whites than in African Americans. There is limited data on the neuropathologic basis of cognitive impairment in African Americans. Integrating post-mortem indices into a study of risk factors for cognitive decline in one of the fastest growing minority groups is highly innovative and has the potential to greatly increase understanding of the ways in which risk factors interact with neuropathology to influence cognition and racial disparities in cognitive test performance. Further, the findings could have important implications for therapeutic intervention and disease prevention.

Public Health Relevance

This project will examine the association of Alzheimer disease pathology and other common neuropathologic indices on risk factors and change in cognitive function over time in older African Americans. An important strength of the study is that it will take advantage of the availability of detailed information on cognitive function and biological and clinical risk factors of interest from the prior project period and supplement it with quantitative postmortem measurements on more than 100 African Americans. Findings from this study are expected to provide a better understanding of the extent to which neuropathologic indices contribute to cognitive impairment in African Americans, and how pathology may interact with important risk factors to effect racial differences in cognitive function.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG022018-09
Application #
8494484
Study Section
Special Emphasis Panel (ZRG1-BBBP-R (02))
Program Officer
Anderson, Dallas
Project Start
2003-04-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$715,523
Indirect Cost
$238,508
Name
Rush University Medical Center
Department
Neurosciences
Type
Schools of Medicine
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Coley, Sheryl L; Mendes de Leon, Carlos F; Ward, Earlise C et al. (2017) Perceived discrimination and health-related quality-of-life: gender differences among older African Americans. Qual Life Res 26:3449-3458
Kapasi, Alifiya; DeCarli, Charles; Schneider, Julie A (2017) Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 134:171-186
Turner, Arlener D; James, Bryan D; Capuano, Ana W et al. (2017) Perceived Stress and Cognitive Decline in Different Cognitive Domains in a Cohort of Older African Americans. Am J Geriatr Psychiatry 25:25-34
Mez, Jesse; Chung, Jaeyoon; Jun, Gyungah et al. (2017) Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans. Alzheimers Dement 13:119-129
Pool, Lindsay R; Weuve, Jennifer; Wilson, Robert S et al. (2016) Occupational cognitive requirements and late-life cognitive aging. Neurology 86:1386-92
Crane, Paul K; Gibbons, Laura E; Dams-O'Connor, Kristen et al. (2016) Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol 73:1062-9
Buchman, Aron S; Wilson, Robert S; Yu, Lei et al. (2016) Motor Function Is Associated With Incident Disability in Older African Americans. J Gerontol A Biol Sci Med Sci 71:696-702
Barnes, Lisa L; Yumoto, Futoshi; Capuano, Ana et al. (2016) Examination of the Factor Structure of a Global Cognitive Function Battery across Race and Time. J Int Neuropsychol Soc 22:66-75
Wilson, Robert S; Capuano, Ana W; Marquez, David X et al. (2016) Change in Cognitive Abilities in Older Latinos. J Int Neuropsychol Soc 22:58-65
Weiss, Aner; Mirelman, Anat; Giladi, Nir et al. (2016) Transition Between the Timed up and Go Turn to Sit Subtasks: Is Timing Everything? J Am Med Dir Assoc 17:864.e9-864.e15

Showing the most recent 10 out of 69 publications